BCCI President Sourav Ganguly is not Omicron infected, may be discharged from hospital today

Delhi | BCCI President Sourav Ganguly is not infected with Omicron virus. The latest coronavirus variant which has resulted in a surge in cases across the world. Ganguly, who was admitted to a hospital in Kolkata earlier this week, came back after the RT-PCR test came back positive. According to media sources, it has been learned that BCCI President Sourav Ganguly is likely to be discharged from the hospital today. ( ganguly discharge today )

also read: Death of two Omicron infected in the country! Omicron’s havoc broke in these two states

Antibody prevents virus from entering human cells

49-year-old Ganguly was immediately given monoclonal antibody cocktail therapy after being admitted to Woodlands Hospital on Monday. The antibody cocktail is a combination of two monoclonal antibodies: casirivimab and imdevimab. Both Imdevimab and Casirivimab are human immunoglobulin G-1 (IgG1) monoclonal antibodies that act against viruses. The antibody cocktail thwarts the attachment of the virus and its entry into the human cell. According to the Emergency Use Authorization (EUA), the cocktail antibody has the potential to treat mild to moderate COVID-19 infection in adults and patients over 12 years of age who are at high risk of developing severe disease and Do not need oxygen.

A daily health bulletin on health ( ganguly discharge today )

The hospital was putting out a daily health bulletin on the health of Ganguly, who remained hemodynamically stable and non-fever. The former India captain was admitted to the hospital earlier this year after complaining of chest discomfort and underwent angioplasty for the second time. His elder brother Snehasish, joint secretary of the Cricket Association of Bengal, also contracted the coronavirus earlier this year. ( ganguly discharge today )

People News Chronicle

People News Chronicle author account is for interns, who are just new to our news agency. They are taught basics of wordpress and publishing through this account.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button